Impact of hydroxyurea dose and adherence on hematologic outcomes for children with sickle cell anemia

INIS

• administration 8%
• children 16%
• comparative evaluations 8%
• data 8%
• doses 58%
• hemoglobin 8%
• hydroxyurea 100%
• implementation 8%
• income 16%
• increasing 8%
• magnesium 20 16%
• males 8%
• medical records 8%
• patients 16%
• range 8%
• sickle cell anemia 25%
• therapy 8%
• variations 8%
• volume 8%

Medicine and Dentistry

• Age 8%
• Analysis 8%
• Child 16%
• Directly Observed Therapy 8%
• Drug Megadose 8%
• Drug Therapy 8%
• Electronic Patient Record 8%
• Embryonic Hemoglobin 8%
• Hydroxyurea 100%
• Inpatient 8%
• Male 8%
• Mean Corpuscular Volume 8%
• Medication Compliance 25%
• Patient Compliance 8%
• Sickle-Cell Disease 25%
• Therapeutic Procedure 8%